Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Satirapoj, Bancha ^a   Aramsaowapak, Kasemsan ^a   Tangwonglert, Theerasak ^a   Supasyndh, Ouppatham ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

AGED; ALBUMINURIA; ARTICLE; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

EID: 84988706053     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/3102962     Document Type: Article

References (31)

1. R. Saran, Y. Li, B. Robinson et al. , "Us renal data system 2014 annual data report: epidemiology of kidney disease in the united states," American Journal of Kidney Diseases, vol. 66, no. 1, supplement 1, pp. S1-305, 2015
2. H. H. Parving, B. Oxenbøll, P. A. Svendsen, J. S. Christiansen, and A. R. Andersen, "Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion," Acta Endocrinologica, vol. 100, no. 4, pp. 550-555, 1982
3. B. Satirapoj and S. G. Adler, "Comprehensive approach to diabetic nephropathy," Kidney Research and Clinical Practice, vol. 33, no. 3, pp. 121-131, 2014
4. P. Fioretto, M. W. Steffes, and M. Mauer, "Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria," Diabetes, vol. 43, no. 11, pp. 1358-1364, 1994
5. C. E. Hills and P. E. Squires, "The role of TGF-α and epithelialto mesenchymal transition in diabetic nephropathy," Cytokine and Growth Factor Reviews, vol. 22, no. 3, pp. 131-139, 2011
6. J. Mishra, K. Mori, Q. Ma et al. , "Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin," Journal of theAmerican Society of Nephrology, vol. 15, no. 12, pp. 3073-3082, 2004
7. H.-J. Bangstad, I. Seljeflot, T. J. Berg, and K. F. Hanssen, "Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes," Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 1, pp. 138-144, 2009
8. B. Jacobsson, H. Lignelid, and U. S. R. Bergerheim, "Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas," Histopathology, vol. 26, no. 6, pp. 559-564, 1995
9. M. L. Graciano, R. D. C. Cavaglieri, H. Dellê et al. , "Intrarenal renin-angiotensin systemis upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis," Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1805-1815, 2004
10. S. S. Kim, S. H. Song, I. J. Kim et al. , "Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients,"Diabetes Research and Clinical Practice, vol. 97, no. 2, pp. 251-257, 2012
11. A. S. Levey, L. A. Stevens, C. H. Schmid et al. , "Anewequation to estimate glomerular filtration rate," Annals of InternalMedicine, vol. 150, no. 9, pp. 604-612, 2009
12. A. A. Eddy and E. G. Neilson, "Chronic kidney disease progression," Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 2964-2966, 2006
13. M. C. Thomas,W. C. Burns, and M. E. Cooper, "Tubular changes in early diabetic nephropathy," Advances in Chronic Kidney Disease, vol. 12, no. 2, pp. 177-186, 2005
14. B. Satirapoj, C. C. Nast, and S. G. Adler, "Novel insights into the relationship between glomerular pathology and progressive kidney disease," Advances in Chronic Kidney Disease, vol. 19, no. 2, pp. 93-100, 2012
15. J. Mishra, Q. Ma, A. Prada et al. , "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury," Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534-2543, 2003
16. Y. Togashi and Y. Miyamoto, "Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats," Experimental and Toxicologic Pathology, vol. 65, no. 5, pp. 615-622, 2013
17. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, "Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury," Kidney International, vol. 62, no. 1, pp. 237-244, 2002
18. B. Gociman, A. Rohrwasser, P. Lantelme et al. , "Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate," Kidney International, vol. 65, no. 6, pp. 2153-2160, 2004
19. J. A. M. de Carvalho, E. Tatsch, B. S. Hausen et al. , "Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes," Clinical Biochemistry, vol. 49, no. 3, pp. 232-236, 2016
20. D. Bolignano, A. Lacquaniti,G. Coppolino, S. Campo, A. Arena, and M. Buemi, "Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease," Kidney and Blood Pressure Research, vol. 31, no. 4, pp. 255-258, 2008
21. B. Satirapoj, N. Siritaweesuk, and O. Supasyndh, "Urinary angiotensinogen as a potential biomarker of diabetic nephropathy," Clinical Kidney Journal, vol. 7, no. 4, pp. 354-360, 2014
22. X. Rao, M. Wan, C. Qiu, and C. Jiang, "Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetesmellitus," Experimental and Therapeutic Medicine, vol. 8, no. 3, pp. 887-892, 2014
23. Y.-H. Yang,X.-J. He,S.-R. Chen, L. Wang,E.-M. Li, and L.-Y. Xu, "Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study," Endocrine, vol. 36, no. 1, pp. 45-51, 2009
24. S. E. Nielsen, H. Reinhard, D. Zdunek et al. , "Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients,"Diabetes Research and Clinical Practice, vol. 97, no. 1, pp. 71-76, 2012
25. N. Nowak, J. Skupien, M. A. Niewczas et al. , "Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes," Kidney International, vol. 89, pp. 459-467, 2016
26. N. M. Panduru, N. Sandholm, C. Forsblom et al. , "Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes," Diabetes Care, vol. 38, no. 6, pp. 1130-1137, 2015
27. S. S. Kim, S. H. Song, I. J. Kim et al. , "Urinary cystatin c and tubular proteinuria predict progression of diabetic nephropathy," Diabetes Care, vol. 36, no. 3, pp. 656-661, 2013
28. N. A. Bhavsar, A. Köttgen, J. Coresh, and B. C. Astor, "Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the atherosclerosis risk in communities (ARIC) study," American Journal of Kidney Diseases, vol. 60, no. 2, pp. 233-240, 2012
29. W.-J. Fu, S.-L. Xiong, Y.-G. Fang et al. , "Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study," Endocrine, vol. 41, no. 1, pp. 82-88, 2012
30. M. L. Alter, A. Kretschmer, K. VonWebsky et al. , "Early urinary and plasma biomarkers for experimental diabetic nephropathy," Clinical Laboratory, vol. 58, no. 7-8, pp. 659-671, 2012
31. V. S. Sabbisetti, S. S. Waikar, D. J. Antoine et al. , "Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes," Journal of the American Society of Nephrology, vol. 25, no. 10, pp. 2177-2186, 2014.